$NDAQ

Smith Bryan Everard sold $240K of NDAQ

Smith Bryan Everard (EVP, CPO) sold 3,000 shares of NASDAQ, INC. (NDAQ) at $80.00 ($0.24M total) on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Smith Bryan Everard
Published Jul 2, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 7:27 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$NDAQ
Neutral
high confidence
Mentioned
$NDAQ
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NDAQNeutralLow
01

Why it matters

The only new fact is the specific sale details: 3,000 shares sold at $80 on 2026-07-01, with holdings after the transaction of 69,203 shares, under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment, but there is no fundamental catalyst or guidance change in the text.

03

What to watch

The article provides no information on whether the sale was part of a larger scheduled program, whether there were concurrent purchases, or whether the insider’s remaining holdings changed materially beyond the post-transaction figure.

Relevance 3/10Novelty 3/10Timing: Filed 2026-07-02 after the sale on 2026-07-01.

Background

The article is a SEC Form 4 insider transaction disclosure for NASDAQ, Inc. (NDAQ).

Company-level read

Ticker impact

$NDAQNeutralHigh confidence
Context

NDAQ disclosed an insider Form 4 showing EVP/CPO Smith Bryan Everard sold 3,000 shares at $80 on 2026-07-01 under a 10b5-1 plan.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and short-lived.

Evidence & confidence

The filing is an open-market sale by an insider under a pre-arranged 10b5-1 plan, with no accompanying operational, financial, or regulatory change described.

Market effects

Minimal; insider sales under 10b5-1 do not typically reset sector expectations for exchanges.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can be interpreted by some traders as a mild confidence signal, especially if it coincides with other negative catalysts not mentioned here.

Key entities

  • NASDAQ, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Smith Bryan Everard

    EVP, CPO who executed an open-market sale under a 10b5-1 plan.

Related articles

$NDAQMed

SEC sets Aug. 24 deadline in Nasdaq Bitcoin options review

The SEC ordered a full Commission review of Nasdaq PHLX’s proposed cash-settled Bitcoin index options (QBTC), after CME Group petitioned against a May 22 staff approval. The SEC set Aug. 24 as the deadline for written comments. The May approval remains stayed pending the Commission’s next order, with CFTC and OCC relief still required.

$CMEMed

CME Challenges Nasdaq Bitcoin Options Approval, Claims CFTC Has Exclusive Jurisdiction — BigGo Finance

CME Group challenged the SEC’s conditional approval of Nasdaq PHLX’s cash-settled bitcoin index options (ticker QBTC). CME says bitcoin is a commodity, so CFTC has exclusive jurisdiction, and the SEC exceeded its authority. The SEC initiated review and kept a stay. Comments are due Aug. 24. QBTC uses CME CF Bitcoin Real-Time Index and is cash-settled in USD.

$NDAQMedAI 8/10

Nasdaq (NDAQ) Q2 2026 Earnings Call Transcript

Nasdaq (NDAQ) reported Q2 2026 net revenue of $1.5 billion, up 15%, and non-GAAP EPS of $1.07, up 25%. Solutions revenue rose 17% to $1.2 billion, with Index AUM reaching $1.114 trillion and $51 billion in quarterly net inflows. The company updated non-GAAP operating expense guidance to $2.530 billion to $2.570 billion and repurchased $356 million of shares.

$NDAQMedAI 9/10

Nasdaq Q2 Earnings: Double-Digit Revenue Growth Across All Divisions

Nasdaq (NDAQ) reported Q2 results with quarterly net revenue of $1.5 billion, up 15% on an adjusted basis. Solutions revenue rose 17% adjusted. ARR increased 11% to $3.3 billion. GAAP diluted EPS was $0.89, up 14%, and non-GAAP EPS was $1.07. Nasdaq also cited record Index AUM and IPO activity, including SpaceX.